Publication | Open Access

Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease

InflammationHeart FailureAnti-inflammatoryInhibits Inflammatory ResponseCardiovascular DiseaseMedicineCardiovascular PharmacologyVascular BiologyGinsenosides CompoundPharmacologyCardiologyCongenital Heart Disease